Story excerpt provided by Dayton Business Journal.
Written by Tristan Navera.
A biotech startup has landed new space, $2.5 million in new capital and is preparing a major clinical trial as it sets up to hit the market this year.
Ischemia Care, founded several years ago in Cincinnati, is lining up its final clinical trial for 1,000 patients, which it hopes to get off the ground in the second quarter of this year. This as founder and CEO Jeff June says he hopes its product — a blood test for timely diagnosis and treatment of strokes — could hit the market as soon as this year.
Click here to read the complete article.
Originally published May 9, 2017.